Researchers have demonstrated that PARL treatment leads to significant lipid peroxidation, glutathione depletion, and GPX4 inactivation in oral cancer cells, confirming that ferroptosis is the primary mechanism [80]. The gene discussed is GPX4; the disease is lip and oral cavity carcinoma.